Our Plan

The Veltmeyer Institute Plan
  • Offer State of the Art Solutions to patients suffering from chronic degenerative conditions for which limited or no medical treatments exist. 
  • Offer advanced Stem Cell Therapy with exclusive rights to the JadiCells.
  • Initiate interventions that increase cell numbers in the blood by utilizing Stem Cells that have FDA Clearance for use in end-stage patients.  To our knowledge, we are the only regenerative medicine company capable of legally offering Stem Cells under the Right to Try Law.
  • Be the first to market JadiCells in the U.S. market with Phase 3 FDA approval.  CAB’s next-generation care is faster, less expensive, and more effective and is Doctor/Patient-centered…we care for the Patient!
  • Work with Therapeutic Solutions International (TSOI) to set up a domestic JadiCells manufacturing facility. 
  • License other Physicians and Clinics that can access JadiCells for patient treatments.
  • Recruit and maintain a network of medical practices through which to distribute the JadiCells. 
  • Be the Number 1 company in the Stem Cell industry with the only product in the marketplace with the efficacy and safety to give patients the comfort of being treated in the U.S, instead of going to Panama, Costa Rica, Mexico or other places in the world for treatments that may or not work.